低级别浆液性卵巢癌诊疗中的社会人口学差异
基于美国国家癌症数据库2004–2015年3221例低级别浆液性卵巢癌患者的数据,分析社会人口学因素与临床特征、治疗及生存的关系。发现黑人和西班牙裔患者诊断年龄更轻且接受化疗更少,政府保险与更差的总生存独立相关,而种族/民族并不预测总生存。
要点
- 黑人和西班牙裔LGSC患者诊断年龄更轻,接受化疗的比例更低。
- 政府保险相比私人保险与更高的30天死亡率和更差的总生存独立相关。
- 年龄、分期和政府保险是总生存的独立预测因素,种族/民族无预测作用。
核心结论
- LGSC患者在社会人口学因素上存在临床特征、治疗和结局的显著差异。
- 黑人和西班牙裔患者诊断更年轻且接受化疗更少。
- 年龄、分期和政府保险预测总生存,种族/民族不预测总生存。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库(NCDB)2004–2015年数据。
- 纳入3221例低级别浆液性卵巢癌患者,包括卵巢、输卵管或腹膜浸润性1级浆液性癌。
- 分析采用ANOVA、卡方检验、Kaplan-Meier法和Cox回归。
主要发现
- 黑人相比白人诊断年龄更轻(50.4 vs. 55.9岁,p < 0.01),接受化疗更少(61.8% vs 67.0%,p = 0.04)。
- 黑人相比白人CA-125升高更少(OR 4.14 [1.26-13.57],p = 0.02)。
- 西班牙裔相比非西班牙裔诊断年龄更轻(49.5 vs. 55.8岁,p < 0.01)且接受化疗更少(55% vs 67%,p < 0.001)。
- 政府保险相比私人保险30天死亡率更高(1.5% vs 0.01%,p < 0.001)。
- 总生存独立预测因素:年龄(HR 1.013 [1.002-1.024],p = 0.03)、晚期分期(HR 3.09 [2.15-4.43],p < 0.001)、政府保险(HR 2.33 [1.65-3.30],p < 0.001)。
临床怎么用
- 临床应关注黑人和西班牙裔LGSC患者诊断年轻且化疗接受率低的现象,促进公平治疗。
- 政府保险患者30天死亡风险更高,需加强围治疗期管理和随访。
- 年龄、分期和保险状态可用于风险分层,帮助识别高危患者。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Low-grade serous carcinoma (LGSC) is a rare histotype of ovarian cancer with a unique disease course. Little data exist regarding the influence of sociodemographic factors on diagnosis and outcomes in this disease. Our objective was to evaluate the associations between these factors and the clinical characteristics, treatment approaches, and survival in LGSC. METHODS: The National Cancer Database (NCDB) was queried for data between 2004 and 2015 on patients with LGSC. LGSC was inclusive of invasive, grade 1, serous carcinoma of the ovary, fallopian tube, or peritoneum. Patient demographics, insurance status, disease characteristics, treatment approach, and survival were evaluated. ANOVA, Chi Square, Kaplan-Meier, and Cox regression were used in the analysis. RESULTS: 3221 patients with LGSC were evaluated (89.5% White, 6.2% Black; 7.2% Hispanic, 92.8% non-Hispanic). Compared to Whites, Blacks were diagnosed younger (50.4 vs. 55.9 years, p < 0.01), received less chemotherapy (61.8% vs 67.0%, p = 0.04), and had less CA-125 elevation (OR 4.14 [1.26-13.57], p = 0.02). Compared to non-Hispanics, Hispanics were younger (49.5 vs. 55.8 years, p < 0.01) and received less chemotherapy (55% vs 67%, p < 0.001). In contrast to private insurance, government insurance was associated with a higher 30-day mortality (1.5% vs 0.01%, p < 0.001). Race/ethnicity were not predictive of OS, while older age (HR 1.013 [1.002-1.024], p = 0.03), advanced stage (HR 3.09 [2.15-4.43], p < 0.001), and government insurance (HR 2.33 [1.65-3.30], p < 0.001) were all independently associated with worse OS. CONCLUSIONS: Significant differences exist in the clinical characteristics, treatments, and outcomes of LGSC by sociodemographics, with Blacks and Hispanics being diagnosed younger and receiving less chemotherapy. Age, stage, and insurance status were predictive of overall survival.
引用
- Siemon J, Galli J, Slomovitz B, et al. Disparities in care among patients with low-grade serous ovarian carcinoma. Gynecol Oncol. 2020. PMID: 32008792. doi:10.1016/j.ygyno.2019.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。